课题基金 / 基金详情

Pre-symptomatic diagnosis and clinical assessment of genetic analysis for familial endocrine tumors

Pre-symptomatic diagnosis and clinical assessment of genetic analysis for familial endocrine tumors
家族性内分泌肿瘤的症状前诊断和基因分析的临床评估
批准号:
11671174
负责人:
IWASAKI Hiroyuki
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2002

项目摘要

项目成果

IWASAKI Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Analyses of MEN-1 gene for endocrine tumorsAccoriding to the initial aim of this project, I studied abnormalities of MEN-1 gene for sporadic endoctrine tumors. The results that the incident of MEN-1 gene mutation for sporadic endocrine tumors was very low suggest that there was different mechanism for tumorigenesis from familial ecdocrine tumors. As far as MEN-1 gene is not responsible gene for sporadic endocrine tumors, it is impossible to produce endocrine tumors by using gene induction technique.2. Genetic analyses of ret-oncogene for familial medullary thyroid carcinoma (FMTC)I studied two families of FMTC and one family of MEN-IIA. Family A , involving three patients with medullary thyroid carcinoma (MTC) and two carriers, was diagnosed FMTC with a RET codon 609 mutation. MTCs in this family were very slow progressive. Clinical strategy of this family is to perform total thyroidectomy for the patient developed MTC. Family B, involving two patients with MTC and two carriers, also was diagnosed FMTC with a RET codon 620 mutation. Family C, involving five patients with MTC, one patient with pheochromocytoma and two carriers, was diagnosed MEN-IIA with a RET codon 634 mutation. I am going to study further these three family members according to the guideline from Japanese Ministry of Health, Labor and Welfare.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
岩崎博幸: "甲状腺癌の疫学に関する最新のデータ"臨床外科増刊号. 57(11). 30-34 (2002)
Hiroyuki Iwasaki:“甲状腺癌流行病学的最新数据”临床外科特刊 57(11) (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroshi Iwasaki: "Newest data of etiology for thyroid carcinoma in Japan"Japanese Journal of Clinical Surgery. 57(11). 30-34 (2002)
Hiroshi Iwasaki:“日本甲状腺癌病因学的最新数据”日本临床外科杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
岩崎 博幸: "甲状腺癌の疫学に関する最新のデータ"臨床外科増刊号. 57(11). 30-34 (2002)
Hiroyuki Iwasaki:“甲状腺癌流行病学的最新数据”临床外科特刊 57(11) (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Study on climatology of lightning diversity and cause of the diversity
  • 批准号:
    18K03739
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2018
  • 负责人:
    IWASAKI Hiroyuki
  • 依托单位:
A Diachronic and Synchronic Study of Swiping in English for Its Comprehensive Understanding
Climatology on the lightning with high energy around Japan
  • 批准号:
    26400463
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2014
  • 负责人:
    IWASAKI Hiroyuki
  • 依托单位:
Study on the fine structure of convective cells in developed cumulonimbus clouds using 10-sec rainfall amount
  • 批准号:
    23654164
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.5万
  • 财政年份:
    2011
  • 负责人:
    IWASAKI Hiroyuki
  • 依托单位:
国内基金
海外基金
MEN1 失活通过 PCP4/NR2F6/MLL1轴调控 MGMT 影响胰腺神经内分泌瘤替莫唑胺化疗耐药的机制研究
  • 批准号:
    25TS1403500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    吉顺荣
  • 依托单位:
MEN1失活通过PCP4/NR2F6/MLL1轴调控MGMT影响胰腺神经内分泌瘤替莫唑胺化疗耐药的机制研究
  • 批准号:
    25TS1403500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    吉顺荣
  • 依托单位:
MEN1失活通过ZDHHC9介导的MGMT棕榈酰化修饰调控胰腺神经内分泌瘤替莫唑胺化疗耐药的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胥俊峰
  • 依托单位:
肺腺癌中MEN1通过调控ZNF146影响肿瘤免疫微环境的功能和机制研究